Global child immunization rates stall despite minor pandemic recovery
In 2025, 90% of infants globally – or nearly 116 million – received at least one dose of…
Tracking Lassa fever survivors provides crucial clues for future vaccines
The University of Maryland School of Medicine Center for Vaccine Development and Global Health (CVD), has announced the…
Animal-free lung model unlocks better treatments for RSV in babies
Future therapies for respiratory syncytial virus (RSV) must target both the virus and its immune response to ensure…
U.S. citizen tests positive for Ebola in Congo
KINSHASA, Congo — A U.S. citizen working for a humanitarian organization in Congo has tested positive for the Ebola virus,…
New viral library helps scientists study thousands of proteins
To prevent viruses from sickening or killing us – whether it’s an individual case of hepatitis B or…
Review highlights traditional Chinese medicine for Chikungunya fever management
Chikungunya fever, caused by Chikungunya virus (CHIKV), has re‑emerged as a major global health threat. The 2025 outbreak…
HIV vaccine candidates reach milestone in primates
Key Insights Vaccinating against HIV has been a decades-long effort, stymied by the virus’s high mutation rate…
New genetic screening method unlocks insights into human development
A new genetic screening method allows researchers to efficiently modulate individual genes across entire tissues and provides new…
New viral insights lay foundation for treating infection with JC polyomaviruses
In people with severely compromised immune systems, the JC polyomavirus can trigger a currently untreatable, usually fatal brain…
WHO launches PARTNERS clinical trial for Bundibugyo virus treatments
In a major international effort to evaluate potential treatments for Ebola disease due to Bundibugyo virus (BVD), the…
Study links diabetes to worse long COVID health outcomes
People with diabetes who have had COVID-19 tend to recover more slowly, experience more long COVID complications, have…
Nasal viruses may drive allergic rhinitis, and ribavirin shows early promise as a targeted spray treatment
A new study suggests that clearing symptom-driving nasal viruses could calm allergic inflammation and open a fresh treatment…